| Dr Michael John Meddows, MD | |
|
134 Business Park Dr, Virginia Beach, VA 23462-6523 | |
| (757) 473-0044 | |
| Not Available |
| Full Name | Dr Michael John Meddows |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 134 Business Park Dr, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497775464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101235695 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlantic Anesthesia, Inc | 4587562152 | 174 |
| Consultants In Pain Management Inc | 1951325950 | 40 |
News Archive
Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology.
Today, Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA) improved progression-free survival (PFS; primary endpoint) and multiple secondary endpoints including overall survival (OS) and overall response rate (ORR) in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL, respectively) in the final analysis of the Phase III RESONATE™-2 (PCYC-1115) trial.
DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic, the world leader in rugged mobile computers.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
› Verified 3 days ago
| Entity Name | Atlantic Anesthesia, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720181514 PECOS PAC ID: 4587562152 Enrollment ID: O20031222000273 |
News Archive
Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology.
Today, Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA) improved progression-free survival (PFS; primary endpoint) and multiple secondary endpoints including overall survival (OS) and overall response rate (ORR) in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL, respectively) in the final analysis of the Phase III RESONATE™-2 (PCYC-1115) trial.
DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic, the world leader in rugged mobile computers.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
› Verified 3 days ago
| Entity Name | Consultants In Pain Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366545154 PECOS PAC ID: 1951325950 Enrollment ID: O20060118000331 |
News Archive
Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology.
Today, Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA) improved progression-free survival (PFS; primary endpoint) and multiple secondary endpoints including overall survival (OS) and overall response rate (ORR) in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL, respectively) in the final analysis of the Phase III RESONATE™-2 (PCYC-1115) trial.
DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic, the world leader in rugged mobile computers.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael John Meddows, MD 134 Business Park Dr, Virginia Beach, VA 23462-6523 Ph: (757) 473-0055 | Dr Michael John Meddows, MD 134 Business Park Dr, Virginia Beach, VA 23462-6523 Ph: (757) 473-0044 |
News Archive
Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology.
Today, Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA) improved progression-free survival (PFS; primary endpoint) and multiple secondary endpoints including overall survival (OS) and overall response rate (ORR) in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL, respectively) in the final analysis of the Phase III RESONATE™-2 (PCYC-1115) trial.
DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic, the world leader in rugged mobile computers.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
› Verified 3 days ago
Gary Jay Waxman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 816 Independence Blvd, Ste 2a, Virginia Beach, VA 23455 Phone: 757-363-6712 Fax: 757-363-6204 | |
Dr. Daphne Michelle Lenox, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0055 | |
Dr. Stephen Michael Bronaugh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0044 | |
Francis T Verfurth, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-8369 | |
George N Vretakis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 138 S Rosemont Rd, Ste 215, Virginia Beach, VA 23452 Phone: 757-431-9551 Fax: 757-431-9663 | |
Dr. Jennifer Nicole Georgi, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0044 | |
Dr. Monford Wolf, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1975 Glenn Mitchell Dr, Suite 300, Virginia Beach, VA 23456 Phone: 757-507-0170 |